OMEPRAZOLE, SODIUM BICARBONATE

OMEPRAZOLE, SODIUM BICARBONATE was reported 954 times

OMEPRAZOLE, SODIUM BICARBONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BENIGN VAGINAL NEOPLASM 2 0.0556
1 CATHETER SITE EXFOLIATION 1 0.0417
2 HAEMATINURIA 1 0.0303
3 OMENTECTOMY 1 0.0227
4 NASAL VALVE COLLAPSE 1 0.0204
5 RENAL GLYCOSURIA 1 0.0147
6 BRONCHIAL OEDEMA 1 0.0106
7 INFUSION SITE HYPOAESTHESIA 1 0.0105
8 SIGNET-RING CELL CARCINOMA 1 0.0100
9 REBOUND ACID HYPERSECRETION 29 0.0096
10 GASTROENTEROSTOMY 1 0.0092
11 INFUSION SITE HYPERSENSITIVITY 1 0.0083
12 OSTEOPOROSIS POSTMENOPAUSAL 1 0.0067
13 GLOMERULAR VASCULAR DISORDER 1 0.0067
14 HYPERTENSIVE NEPHROPATHY 7 0.0066
15 RENAL HYPERTENSION 2 0.0064
16 ULTRASOUND DOPPLER ABNORMAL 1 0.0058
17 NEPHROGENIC ANAEMIA 26 0.0056
18 ELECTIVE SURGERY 1 0.0054
19 ARTERIAL INSUFFICIENCY 1 0.0054
20 STENT MALFUNCTION 1 0.0051
21 TRACHEOSTOMY MALFUNCTION 1 0.0048
22 HYPERPARATHYROIDISM SECONDARY 12 0.0048
23 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
24 SUPERIOR MESENTERIC ARTERY SYNDROME 1 0.0045
25 ADENOCARCINOMA GASTRIC 4 0.0043
26 CHRONIC KIDNEY DISEASE 326 0.0043
27 LARYNX IRRITATION 1 0.0043
28 END STAGE RENAL DISEASE 77 0.0042
29 PARANASAL SINUS HYPOSECRETION 1 0.0040
30 CAPILLARY FRAGILITY 2 0.0039
31 RENAL HAEMANGIOMA 3 0.0038
32 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 1 0.0037
33 GASTRIC CANCER STAGE III 3 0.0037
34 ORTHOSTATIC HYPERTENSION 2 0.0034
35 BREAST ENGORGEMENT 1 0.0034
36 DEVICE RELATED BACTERAEMIA 1 0.0032
37 TYPHOID FEVER 1 0.0031
38 VAGINAL CANCER 1 0.0031
39 RENAL INJURY 91 0.0031
40 NEPHROSTOMY 1 0.0030
41 SPINAL NERVE STIMULATOR IMPLANTATION 1 0.0029
42 TRACHEAL HAEMORRHAGE 1 0.0028
43 ALLERGIC COUGH 2 0.0026
44 SUICIDE THREAT 1 0.0026
45 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 1 0.0025
46 PARATHYROID DISORDER 2 0.0025
47 VERTEBRAL OSTEOPHYTE 1 0.0023
48 TUBULOINTERSTITIAL NEPHRITIS 43 0.0023
49 DIABETIC NEPHROPATHY 5 0.0023
50 GASTRIC OPERATION 2 0.0022
51 BLOOD THYROID STIMULATING HORMONE 1 0.0021
52 GASTRECTOMY 2 0.0020
53 NEPHROPATHY 18 0.0019
54 INCORRECT PRODUCT ADMINISTRATION DURATION 41 0.0019
55 FAECAL VOMITING 1 0.0019
56 HYPERTROPHY 1 0.0018
57 BLOOD MAGNESIUM ABNORMAL 1 0.0018
58 RIGHT VENTRICULAR DILATATION 1 0.0017
59 IRREGULAR BREATHING 1 0.0017
60 DEVICE MAINTENANCE ISSUE 1 0.0017
61 GASTROINTESTINAL POLYP HAEMORRHAGE 1 0.0017
62 NASAL SEPTUM PERFORATION 1 0.0015
63 INFUSION SITE URTICARIA 1 0.0015
64 HEAD AND NECK CANCER 1 0.0015
65 URETHRAL STENOSIS 1 0.0015
66 RENAL ARTERY STENOSIS 2 0.0015
67 CLEAR CELL RENAL CELL CARCINOMA 1 0.0014
68 CERVICAL RADICULOPATHY 1 0.0014
69 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
70 FINGER AMPUTATION 1 0.0014
71 RESPIRATORY TRACT OEDEMA 1 0.0013
72 BLISTER RUPTURE 1 0.0013
73 CORNEAL DEPOSITS 1 0.0013
74 GASTRIC CANCER STAGE II 1 0.0013
75 HEART SOUNDS ABNORMAL 1 0.0013
76 RENAL CANCER METASTATIC 1 0.0013
77 STOMACH MASS 1 0.0013
78 HEAT EXHAUSTION 1 0.0012
79 CARTILAGE ATROPHY 1 0.0012
80 DEVICE INFUSION ISSUE 3 0.0012
81 CARDIAC STRESS TEST ABNORMAL 1 0.0012
82 ARTHROPOD STING 2 0.0012
83 OESOPHAGEAL PERFORATION 1 0.0012
84 HYPERCHLORHYDRIA 7 0.0012
85 CONGENITAL CYSTIC KIDNEY DISEASE 1 0.0012
86 ENZYME LEVEL INCREASED 1 0.0012
87 RENAL FAILURE 155 0.0012
88 INFUSION SITE DISCOLOURATION 1 0.0011
89 CARDIAC OUTPUT DECREASED 1 0.0011
90 PROTEIN URINE 1 0.0011
91 ACUTE KIDNEY INJURY 168 0.0011
92 CALCIPHYLAXIS 2 0.0011
93 BIOPSY 1 0.0011
94 MENINGIOMA BENIGN 1 0.0011
95 CATHETER SITE SWELLING 1 0.0011
96 WRONG SCHEDULE 1 0.0010
97 PRODUCT AFTER TASTE 1 0.0010
98 INJECTION SITE SCAB 1 0.0010
99 DEVICE POWER SOURCE ISSUE 3 0.0010
100 LYMPHADENECTOMY 1 0.0010
101 STOMA COMPLICATION 1 0.0010
102 LIGHT CHAIN ANALYSIS INCREASED 1 0.0010
103 WAIST CIRCUMFERENCE INCREASED 1 0.0010
104 URETEROLITHIASIS 1 0.0010
105 CARPAL TUNNEL DECOMPRESSION 1 0.0009
106 BLADDER DILATATION 1 0.0009
107 RIGHT VENTRICULAR DYSFUNCTION 1 0.0009
108 SOFT TISSUE DISORDER 1 0.0009
109 NEPHROSCLEROSIS 1 0.0009
110 CHRONIC GASTRITIS 2 0.0009
111 DRUG EFFECT VARIABLE 1 0.0009
112 NEPHROGENIC DIABETES INSIPIDUS 1 0.0009
113 APPLICATION SITE DISCHARGE 1 0.0009
114 INFUSION SITE INFECTION 2 0.0009
115 INFECTED CYST 1 0.0008
116 GASTROINTESTINAL OBSTRUCTION 2 0.0008
117 PHARYNGEAL INFLAMMATION 1 0.0008
118 OTITIS EXTERNA 1 0.0008
119 RENAL ATROPHY 1 0.0008
120 PLATELET DISORDER 2 0.0008
121 POSTOPERATIVE WOUND COMPLICATION 1 0.0008
122 INFUSION SITE IRRITATION 1 0.0008
123 THERAPEUTIC PRODUCT EFFECT VARIABLE 3 0.0008
124 CALCIUM DEFICIENCY 1 0.0008
125 IMPLANTABLE DEFIBRILLATOR INSERTION 1 0.0008
126 PHARYNGEAL ULCERATION 1 0.0008
127 URETERIC OBSTRUCTION 1 0.0007
128 INCISIONAL HERNIA 1 0.0007
129 PRERENAL FAILURE 1 0.0007
130 TONIC CONVULSION 1 0.0007
131 BLOOD ELECTROLYTES DECREASED 1 0.0007
132 POST HERPETIC NEURALGIA 1 0.0007
133 NOROVIRUS INFECTION 1 0.0007
134 DYSPNOEA AT REST 2 0.0007
135 INFUSION SITE INDURATION 1 0.0007
136 ANGIOPLASTY 1 0.0007
137 RUBBER SENSITIVITY 1 0.0007
138 CALCULUS URINARY 1 0.0006
139 RENAL FUNCTION TEST ABNORMAL 3 0.0006
140 EYE ALLERGY 1 0.0006
141 GASTROSTOMY 1 0.0006
142 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
143 INFUSION SITE SWELLING 4 0.0006
144 METABOLIC ALKALOSIS 1 0.0006
145 INFUSION SITE HAEMORRHAGE 2 0.0006
146 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
147 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
148 TONSILLAR HYPERTROPHY 1 0.0006
149 SALMONELLOSIS 1 0.0006
150 LAZINESS 1 0.0006
151 ACUTE SINUSITIS 1 0.0006
152 GASTROOESOPHAGEAL REFLUX DISEASE 46 0.0006
153 INFUSION SITE DISCHARGE 1 0.0006
154 LIVER TRANSPLANT REJECTION 1 0.0006
155 DEVICE ALARM ISSUE 1 0.0006
156 ESSENTIAL HYPERTENSION 1 0.0005
157 BODY TEMPERATURE ABNORMAL 1 0.0005
158 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
159 HYPERTENSIVE HEART DISEASE 1 0.0005
160 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
161 NASAL SEPTUM DEVIATION 1 0.0005
162 PYELONEPHRITIS ACUTE 1 0.0005
163 HYPERAEMIA 1 0.0005
164 UNDERWEIGHT 1 0.0005
165 VOCAL CORD DISORDER 1 0.0005
166 DEVICE RELATED SEPSIS 1 0.0005
167 NIPPLE PAIN 1 0.0005
168 RENAL MASS 1 0.0005
169 CHEST INJURY 1 0.0005
170 SKIN INDURATION 1 0.0005
171 INFUSION SITE EXTRAVASATION 3 0.0005
172 INFUSION SITE ERYTHEMA 4 0.0005
173 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
174 INFUSION SITE PAIN 6 0.0005
175 SPUTUM INCREASED 1 0.0005
176 REACTION TO DRUG EXCIPIENTS 1 0.0005
177 GASTRIC BYPASS 1 0.0005
178 PULMONARY FUNCTION TEST DECREASED 2 0.0005
179 BIPOLAR I DISORDER 1 0.0005
180 MIDDLE EAR EFFUSION 1 0.0005
181 GASTROINTESTINAL ULCER 1 0.0005
182 LARGE INTESTINAL OBSTRUCTION 1 0.0004
183 RENAL COLIC 1 0.0004
184 VASCULAR DEVICE INFECTION 2 0.0004
185 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
186 ORAL PRURITUS 1 0.0004
187 DIALYSIS 6 0.0004
188 URINE FLOW DECREASED 1 0.0004
189 OXYGEN CONSUMPTION INCREASED 1 0.0004
190 HAEMATOLOGICAL INFECTION 1 0.0004
191 GLOMERULONEPHRITIS 1 0.0004
192 BREATH SOUNDS ABNORMAL 2 0.0004
193 HOSPICE CARE 4 0.0004
194 CATHETER SITE HAEMORRHAGE 1 0.0004
195 METASTASES TO PERITONEUM 1 0.0004
196 EAR CONGESTION 1 0.0004
197 GASTRIC CANCER 9 0.0004
198 JOINT LOCK 1 0.0004
199 OESOPHAGEAL STENOSIS 1 0.0004
200 HEART VALVE INCOMPETENCE 1 0.0003
201 LUNG CANCER METASTATIC 1 0.0003
202 EYELID MARGIN CRUSTING 1 0.0003
203 ELECTROLYTE IMBALANCE 4 0.0003
204 PULMONARY PAIN 1 0.0003
205 STRIDOR 1 0.0003
206 URINE ANALYSIS ABNORMAL 1 0.0003
207 EMERGENCY CARE 1 0.0003
208 INTRACARDIAC THROMBUS 1 0.0003
209 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
210 BLOOD BLISTER 1 0.0003
211 BLADDER PAIN 1 0.0003
212 ORTHOPNOEA 1 0.0003
213 FOREIGN BODY SENSATION IN EYES 2 0.0003
214 VENTRICULAR HYPOKINESIA 1 0.0003
215 RENAL TUBULAR NECROSIS 3 0.0003
216 LYME DISEASE 1 0.0003
217 ANXIETY DISORDER 1 0.0003
218 TONGUE ULCERATION 1 0.0003
219 PRODUCT LABEL ISSUE 2 0.0003
220 APPLICATION SITE DRYNESS 1 0.0003
221 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
222 BLOOD TESTOSTERONE DECREASED 2 0.0003
223 CORONARY ARTERY OCCLUSION 4 0.0003
224 LEFT VENTRICULAR FAILURE 1 0.0003
225 SCRATCH 3 0.0003
226 INCONTINENCE 3 0.0003
227 RENAL PAIN 3 0.0003
228 APPENDICECTOMY 1 0.0003
229 FRUSTRATION 1 0.0003
230 RENAL TRANSPLANT 1 0.0003
231 MONOCYTE COUNT INCREASED 1 0.0003
232 SCLERODERMA 1 0.0003
233 THROMBOCYTOSIS 1 0.0003
234 HYPOMANIA 1 0.0003
235 FREEZING PHENOMENON 1 0.0003
236 CHRONIC SINUSITIS 1 0.0003
237 REBOUND EFFECT 3 0.0003
238 SNORING 1 0.0003
239 AUTOIMMUNE THYROIDITIS 1 0.0003
240 PARANASAL SINUS DISCOMFORT 1 0.0003
241 OSTEOPENIA 4 0.0003
242 PARANASAL SINUS HYPERSECRETION 1 0.0003
243 INSURANCE ISSUE 4 0.0003
244 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
245 THYROID MASS 1 0.0003
246 OESOPHAGEAL ULCER 1 0.0003
247 OESOPHAGEAL DISORDER 1 0.0003
248 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
249 CARDIOPULMONARY FAILURE 1 0.0003
250 ORAL INFECTION 1 0.0003
251 MULTIPLE ALLERGIES 2 0.0003
252 KIDNEY INFECTION 5 0.0003
253 PROSTATOMEGALY 1 0.0003
254 RESPIRATORY ACIDOSIS 1 0.0003
255 OESOPHAGEAL PAIN 1 0.0003
256 RENAL CYST 2 0.0003
257 HYPERLIPIDAEMIA 3 0.0003
258 OESOPHAGEAL CANDIDIASIS 1 0.0003
259 ARTERIOSPASM CORONARY 1 0.0002
260 NOCTURIA 3 0.0002
261 VITAMIN B12 DEFICIENCY 1 0.0002
262 POLYURIA 2 0.0002
263 SOCIAL PROBLEM 1 0.0002
264 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
265 SECRETION DISCHARGE 3 0.0002
266 SLEEP TERROR 1 0.0002
267 SENSATION OF FOREIGN BODY 2 0.0002
268 MUSCLE FATIGUE 1 0.0002
269 TONGUE DISCOMFORT 1 0.0002
270 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
271 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
272 ABNORMAL SENSATION IN EYE 1 0.0002
273 TEARFULNESS 1 0.0002
274 DEVICE OPERATIONAL ISSUE 1 0.0002
275 HIATUS HERNIA 3 0.0002
276 HORDEOLUM 1 0.0002
277 PYELONEPHRITIS 2 0.0002
278 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
279 DIVERTICULUM INTESTINAL 1 0.0002
280 NAIL DISORDER 2 0.0002
281 ONYCHOMYCOSIS 1 0.0002
282 TOOTH INFECTION 3 0.0002
283 BLOOD CREATINE INCREASED 1 0.0002
284 CATHETERISATION CARDIAC 1 0.0002
285 RHINITIS ALLERGIC 1 0.0002
286 IRON DEFICIENCY 1 0.0002
287 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
288 HAEMOGLOBIN INCREASED 1 0.0002
289 INJECTION SITE PAPULE 1 0.0002
290 EYE OPERATION 1 0.0002
291 LOCALISED OEDEMA 1 0.0002
292 ARTHRITIS INFECTIVE 1 0.0002
293 SKIN TIGHTNESS 1 0.0002
294 VAGINAL INFECTION 1 0.0002
295 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
296 SUBDURAL HAEMATOMA 3 0.0002
297 LIMB OPERATION 1 0.0002
298 AFFECT LABILITY 2 0.0002
299 ATELECTASIS 2 0.0002
300 LOCALISED INFECTION 5 0.0002
301 ERUCTATION 4 0.0002
302 VITAMIN D DEFICIENCY 2 0.0002
303 HYPERVOLAEMIA 1 0.0002
304 RENAL IMPAIRMENT 17 0.0002
305 BLADDER DISORDER 2 0.0002
306 HYPERNATRAEMIA 1 0.0002
307 APPLICATION SITE SWELLING 1 0.0002
308 DYSPHORIA 1 0.0002
309 INITIAL INSOMNIA 2 0.0002
310 WEIGHT FLUCTUATION 2 0.0002
311 DYSURIA 7 0.0002
312 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
313 IRRITABLE BOWEL SYNDROME 4 0.0002
314 INJECTION SITE DISCHARGE 1 0.0002
315 BEHAVIOUR DISORDER 1 0.0002
316 PHARYNGITIS STREPTOCOCCAL 2 0.0002
317 HIP SURGERY 1 0.0002
318 SKIN LACERATION 2 0.0002
319 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
320 WOUND INFECTION 2 0.0002
321 ASPIRATION 2 0.0002
322 MULTIPLE FRACTURES 3 0.0002
323 CHOKING SENSATION 1 0.0002
324 HYPERKERATOSIS 1 0.0002
325 NERVE INJURY 2 0.0002
326 EYE INFECTION 2 0.0002
327 MITRAL VALVE INCOMPETENCE 2 0.0002
328 PERONEAL NERVE PALSY 1 0.0002
329 DERMATITIS CONTACT 2 0.0002
330 MICTURITION URGENCY 2 0.0002
331 NEPHROLITHIASIS 8 0.0002
332 MUSCULOSKELETAL DISCOMFORT 3 0.0002
333 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
334 RALES 1 0.0002
335 HYPOVOLAEMIA 1 0.0002
336 CARDIAC PACEMAKER INSERTION 1 0.0002
337 WRIST FRACTURE 2 0.0002
338 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 30 0.0002
339 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
340 TYPE 1 DIABETES MELLITUS 1 0.0002
341 ADRENAL INSUFFICIENCY 2 0.0002
342 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
343 MENISCUS INJURY 1 0.0002
344 LARYNGEAL OEDEMA 1 0.0002
345 INJECTION SITE EXTRAVASATION 2 0.0002
346 SCOLIOSIS 1 0.0002
347 OLIGURIA 1 0.0002
348 PRE-EXISTING CONDITION IMPROVED 1 0.0002
349 EYE PAIN 9 0.0002
350 PROTEINURIA 3 0.0002
351 FEELING JITTERY 3 0.0002
352 THROAT IRRITATION 7 0.0002
353 APPLICATION SITE VESICLES 1 0.0002
354 BEDRIDDEN 2 0.0002
355 ORAL CANDIDIASIS 2 0.0002
356 PULMONARY CONGESTION 2 0.0002
357 CORONAVIRUS INFECTION 1 0.0002
358 APPETITE DISORDER 1 0.0002
359 EXPIRED PRODUCT ADMINISTERED 5 0.0002
360 EAR INFECTION 4 0.0002
361 CARDIAC FAILURE ACUTE 1 0.0001
362 PRODUCT ADMINISTRATION ERROR 3 0.0001
363 METASTASES TO LYMPH NODES 1 0.0001
364 POSTOPERATIVE WOUND INFECTION 1 0.0001
365 FEEDING DISORDER 3 0.0001
366 PRODUCT TASTE ABNORMAL 2 0.0001
367 OCULAR HYPERAEMIA 7 0.0001
368 LIMB INJURY 4 0.0001
369 GASTRIC DISORDER 5 0.0001
370 APHONIA 2 0.0001
371 DEFAECATION URGENCY 1 0.0001
372 SEASONAL ALLERGY 2 0.0001
373 HAND FRACTURE 1 0.0001
374 DIVERTICULUM 1 0.0001
375 PRODUCT SUPPLY ISSUE 1 0.0001
376 MAJOR DEPRESSION 1 0.0001
377 INFUSION RELATED REACTION 9 0.0001
378 BLINDNESS TRANSIENT 1 0.0001
379 SENSITIVE SKIN 1 0.0001
380 ARTHROPOD BITE 1 0.0001
381 BLOOD POTASSIUM DECREASED 4 0.0001
382 DERMATITIS ATOPIC 7 0.0001
383 HYPOAESTHESIA ORAL 2 0.0001
384 HAEMODYNAMIC INSTABILITY 1 0.0001
385 BOWEL MOVEMENT IRREGULARITY 1 0.0001
386 DEVICE RELATED INFECTION 2 0.0001
387 ANKLE FRACTURE 2 0.0001
388 DELUSION 2 0.0001
389 BLOOD CHOLESTEROL INCREASED 6 0.0001
390 GASTROINTESTINAL INFLAMMATION 1 0.0001
391 AFFECTIVE DISORDER 1 0.0001
392 PRODUCT USE COMPLAINT 2 0.0001
393 METABOLIC ACIDOSIS 4 0.0001
394 UTERINE CANCER 1 0.0001
395 HIP FRACTURE 4 0.0001
396 BACK DISORDER 2 0.0001
397 DECUBITUS ULCER 1 0.0001
398 HYPERAESTHESIA 1 0.0001
399 BRONCHITIS 9 0.0001
400 ESCHERICHIA INFECTION 1 0.0001
401 VIRAL INFECTION 4 0.0001
402 PNEUMONIA ASPIRATION 3 0.0001
403 EOSINOPHIL COUNT INCREASED 1 0.0001
404 POLLAKIURIA 5 0.0001
405 BLOOD UREA INCREASED 2 0.0001
406 CARDIAC OPERATION 1 0.0001
407 ANURIA 1 0.0001
408 BLOOD MAGNESIUM DECREASED 1 0.0001
409 URINE OUTPUT DECREASED 1 0.0001
410 SPINAL OSTEOARTHRITIS 1 0.0001
411 LUNG INFILTRATION 1 0.0001
412 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
413 GALLBLADDER DISORDER 2 0.0001
414 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
415 GOUT 2 0.0001
416 FREQUENT BOWEL MOVEMENTS 3 0.0001
417 GASTROENTERITIS VIRAL 2 0.0001
418 BONE DISORDER 2 0.0001
419 NERVE COMPRESSION 1 0.0001
420 IRON DEFICIENCY ANAEMIA 1 0.0001
421 PRODUCT DISTRIBUTION ISSUE 1 0.0001
422 CONJUNCTIVITIS 2 0.0001
423 SINUSITIS 11 0.0001
424 APPENDICITIS 1 0.0001
425 OXYGEN SATURATION DECREASED 6 0.0001
426 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
427 ARTERIOSCLEROSIS 1 0.0001
428 SQUAMOUS CELL CARCINOMA 1 0.0001
429 INTESTINAL OBSTRUCTION 4 0.0001
430 SPINAL DISORDER 1 0.0001
431 ABDOMINAL DISTENSION 11 0.0001
432 PRODUCT PACKAGING ISSUE 1 0.0001
433 GASTRIC ULCER 2 0.0001
434 SLEEP APNOEA SYNDROME 2 0.0001
435 HYPERSOMNIA 3 0.0001
436 PRODUCT SUBSTITUTION ISSUE 6 0.0001
437 HYPERCHOLESTEROLAEMIA 1 0.0001
438 PRESCRIBED OVERDOSE 2 0.0001
439 EAR PAIN 2 0.0001
440 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
441 PHARYNGEAL SWELLING 1 0.0001
442 EMBEDDED DEVICE 1 0.0001
443 INABILITY TO AFFORD MEDICATION 1 0.0001
444 EXTRA DOSE ADMINISTERED 4 0.0001
445 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
446 DRY THROAT 1 0.0001
447 OSTEOPOROSIS 4 0.0001
448 RIB FRACTURE 2 0.0001
449 ILLNESS 10 0.0001
450 POOR VENOUS ACCESS 1 0.0001
451 VENTRICULAR EXTRASYSTOLES 1 0.0001
452 EYE DISCHARGE 1 0.0001
453 PETECHIAE 1 0.0001
454 PRODUCT ODOUR ABNORMAL 1 0.0001
455 INJECTION SITE DISCOMFORT 1 0.0001
456 HYPERTENSION 20 0.0001
457 OSTEOARTHRITIS 4 0.0001
458 CYSTITIS 3 0.0001
459 BODY HEIGHT DECREASED 1 0.0001
460 HEREDITARY ANGIOEDEMA 1 0.0001
461 POOR QUALITY SLEEP 2 0.0001
462 PRURITUS GENERALISED 2 0.0001
463 FAECES DISCOLOURED 2 0.0001
464 PRODUCT DOSE OMISSION 6 0.0001
465 OESOPHAGITIS 1 0.0001
466 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
467 COVID-19 16 0.0001
468 STAPHYLOCOCCAL INFECTION 3 0.0001
469 GASTROINTESTINAL PAIN 1 0.0001
470 DENTAL CARIES 1 0.0001
471 FOOT DEFORMITY 1 0.0001
472 FUNGAL INFECTION 3 0.0001
473 ARTHROPATHY 5 0.0001
474 TOOTH DISORDER 2 0.0001
475 URINARY RETENTION 3 0.0001
476 MALNUTRITION 1 0.0001
477 EYE PRURITUS 3 0.0001
478 OCULAR DISCOMFORT 1 0.0001
479 FLATULENCE 5 0.0001
480 MYOCARDIAL ISCHAEMIA 1 0.0001
481 SCAB 1 0.0001
482 HAEMATURIA 3 0.0001
483 INTERNAL HAEMORRHAGE 1 0.0001
484 MUSCLE TWITCHING 2 0.0001
485 HYPOKALAEMIA 4 0.0001
486 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
487 PERICARDIAL EFFUSION 2 0.0001
488 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
489 MADAROSIS 1 0.0001
490 RENAL DISORDER 4 0.0001
491 PRODUCT DOSE OMISSION ISSUE 25 0.0001
492 COVID-19 PNEUMONIA 1 0.0001
493 TREMOR 14 0.0001
494 MUSCLE RIGIDITY 1 0.0001
495 BURSITIS 1 0.0001
496 PANIC ATTACK 3 0.0001
497 NEURALGIA 2 0.0001
498 NO THERAPEUTIC RESPONSE 1 0.0001
499 RESPIRATORY DEPRESSION 1 0.0001
500 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
501 SPINAL OPERATION 1 0.0001
502 TENDON RUPTURE 1 0.0001
503 HYPERCALCAEMIA 1 0.0001
504 GENERALISED OEDEMA 1 0.0001
505 PHARYNGITIS 1 0.0001
506 DRY EYE 4 0.0001
507 DYSPNOEA EXERTIONAL 3 0.0001
508 DEPRESSION 18 0.0001
509 ABDOMINAL PAIN LOWER 2 0.0001
510 TACHYCARDIA 7 0.0001
511 DIABETES MELLITUS 6 0.0001
512 FLUID RETENTION 4 0.0001
513 ERECTILE DYSFUNCTION 2 0.0001
514 ROTATOR CUFF SYNDROME 1 0.0001
515 ANAPHYLACTIC SHOCK 2 0.0001
516 SKIN ULCER 2 0.0001
517 NERVOUSNESS 4 0.0001
518 DEAFNESS 2 0.0001
519 INFECTION 11 0.0001
520 ADVERSE REACTION 1 0.0001
521 COUGH 21 0.0001
522 THROMBOSIS 6 0.0001
523 SINUS CONGESTION 1 0.0001
524 TACHYPNOEA 1 0.0001
525 IMPAIRED GASTRIC EMPTYING 1 0.0001
526 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
527 ORAL DISCOMFORT 1 0.0001
528 FEELING COLD 2 0.0001
529 INFLUENZA 8 0.0001
530 DEMENTIA 2 0.0001
531 ABDOMINAL DISCOMFORT 12 0.0001
532 CARPAL TUNNEL SYNDROME 1 0.0001
533 DYSPEPSIA 7 0.0001
534 DEVICE OCCLUSION 1 0.0001
535 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
536 NASOPHARYNGITIS 13 0.0001
537 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
538 ANXIETY 20 0.0001
539 INTENTIONAL DOSE OMISSION 2 0.0001
540 HYPOACUSIS 3 0.0001
541 EYE IRRITATION 4 0.0001
542 PARAESTHESIA ORAL 1 0.0001
543 DEVICE LEAKAGE 3 0.0001
544 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
545 SEPTIC SHOCK 3 0.0001
546 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
547 GASTROENTERITIS 1 0.0001
548 DRUG INEFFECTIVE 89 0.0001
549 URINARY INCONTINENCE 2 0.0001
550 DYSGEUSIA 5 0.0001
551 PULMONARY MASS 1 0.0001
552 COLON CANCER 1 0.0001
553 RESPIRATORY DISORDER 2 0.0001
554 THERAPY NON-RESPONDER 3 0.0001
555 BONE LOSS 1 0.0001
556 LACRIMATION INCREASED 2 0.0001
557 ECONOMIC PROBLEM 1 0.0001
558 DEVICE FAILURE 1 0.0001
559 DRUG DISPENSING ERROR 1 0.0001
560 TINNITUS 3 0.0001
561 HIP ARTHROPLASTY 1 0.0001
562 THYROID DISORDER 1 0.0001
563 PNEUMONIA 21 0.0001
564 MUSCULOSKELETAL CHEST PAIN 1 0.0001
565 BONE DENSITY DECREASED 2 0.0001
566 CYANOSIS 1 0.0001
567 ARTHRITIS 5 0.0001
568 HEAD INJURY 2 0.0001
569 ABDOMINAL PAIN UPPER 13 0.0001
570 RESPIRATORY TRACT CONGESTION 1 0.0001
571 MIGRAINE 6 0.0001
572 OBESITY 1 0.0001
573 SCIATICA 1 0.0001
574 ABSCESS 1 0.0001
575 CONTUSION 6 0.0001
576 INCORRECT DOSE ADMINISTERED 14 0.0001
577 CONSTIPATION 13 0.0001
578 CELLULITIS 3 0.0001
579 CANDIDA INFECTION 1 0.0001
580 HEMIPARESIS 1 0.0001
581 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
582 THERAPY CESSATION 3 0.0001
583 MEMORY IMPAIRMENT 8 0.0001
584 INFLAMMATION 3 0.0001
585 BALANCE DISORDER 5 0.0001
586 RASH MACULAR 2 0.0001
587 DEVICE USE ISSUE 1 0.0001
588 DEPRESSED MOOD 3 0.0001
589 COLD SWEAT 1 0.0001
590 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
591 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
592 THIRST 1 0.0001
593 HEADACHE 35 0.0001
594 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
595 OEDEMA 3 0.0001
596 OSTEOMYELITIS 1 0.0001
597 RESTLESS LEGS SYNDROME 1 0.0001
598 DYSPNOEA 31 0.0001
599 ACCIDENTAL OVERDOSE 2 0.0001
600 RESTLESSNESS 2 0.0001
601 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
602 NAUSEA 43 0.0001
603 FEELING ABNORMAL 13 0.0001
604 HYPERSENSITIVITY 10 0.0001
605 EYE SWELLING 2 0.0001
606 BACTERIAL INFECTION 1 0.0001
607 MIDDLE INSOMNIA 1 0.0001
608 BLISTER 3 0.0001
609 PHOTOPHOBIA 1 0.0001
610 BLOOD SODIUM DECREASED 1 0.0001
611 UNEVALUABLE EVENT 4 0.0001
612 RHEUMATOID ARTHRITIS 6 0.0001
613 COLITIS 2 0.0001
614 FOOT FRACTURE 1 0.0001
615 DYSPHAGIA 5 0.0001
616 NEUROPATHY PERIPHERAL 5 0.0001
617 DEHYDRATION 7 0.0001
618 INCREASED APPETITE 1 0.0001
619 PRURITUS 20 0.0001
620 ACUTE RESPIRATORY FAILURE 1 0.0001
621 PERIPHERAL SWELLING 8 0.0001
622 HERNIA 1 0.0001
623 PLASMA CELL MYELOMA 2 0.0001
624 CHOKING 1 0.0001
625 ORAL HERPES 1 0.0001
626 SKIN FISSURES 1 0.0001
627 NASAL CONGESTION 3 0.0001
628 DISABILITY 1 0.0001
629 HAEMATOCRIT DECREASED 1 0.0001
630 WEIGHT DECREASED 14 0.0001
631 SPINAL FRACTURE 1 0.0000
632 FULL BLOOD COUNT DECREASED 1 0.0000
633 PLEURAL EFFUSION 3 0.0000
634 DRY MOUTH 4 0.0000
635 TASTE DISORDER 1 0.0000
636 DISCOMFORT 3 0.0000
637 CHEST DISCOMFORT 5 0.0000
638 CHEST PAIN 9 0.0000
639 CARDIAC ARREST 4 0.0000
640 TOOTH LOSS 1 0.0000
641 PULMONARY HYPERTENSION 1 0.0000
642 SKIN EXFOLIATION 4 0.0000
643 DECREASED APPETITE 11 0.0000
644 RETCHING 1 0.0000
645 URINARY TRACT INFECTION 8 0.0000
646 JOINT INJURY 1 0.0000
647 SKIN CANCER 1 0.0000
648 DEEP VEIN THROMBOSIS 3 0.0000
649 AMNESIA 3 0.0000
650 VAGINAL HAEMORRHAGE 2 0.0000
651 MENTAL DISORDER 2 0.0000
652 BLOOD CREATININE INCREASED 3 0.0000
653 HOSPITALISATION 7 0.0000
654 BLOOD PRESSURE DECREASED 3 0.0000
655 LIVER DISORDER 2 0.0000
656 TRANSAMINASES INCREASED 1 0.0000
657 RASH MACULO-PAPULAR 1 0.0000
658 GLOSSODYNIA 1 0.0000
659 ORAL PAIN 1 0.0000
660 SNEEZING 1 0.0000
661 HEART RATE IRREGULAR 1 0.0000
662 APPLICATION SITE PRURITUS 1 0.0000
663 PRODUCT AVAILABILITY ISSUE 1 0.0000
664 OROPHARYNGEAL PAIN 4 0.0000
665 ABDOMINAL PAIN 10 0.0000
666 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
667 PALPITATIONS 5 0.0000
668 THERAPY INTERRUPTED 3 0.0000
669 PRODUCTIVE COUGH 2 0.0000
670 MULTIPLE SCLEROSIS 2 0.0000
671 BLOOD PRESSURE FLUCTUATION 1 0.0000
672 INTERSTITIAL LUNG DISEASE 2 0.0000
673 HYPOGLYCAEMIA 2 0.0000
674 MALAISE 18 0.0000
675 OEDEMA PERIPHERAL 5 0.0000
676 LUNG DISORDER 2 0.0000
677 LIVER INJURY 1 0.0000
678 DEATH 35 0.0000
679 HEART RATE INCREASED 4 0.0000
680 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
681 HYPOAESTHESIA 6 0.0000
682 AGGRESSION 2 0.0000
683 ASTHENIA 15 0.0000
684 HALLUCINATION 3 0.0000
685 SOMNOLENCE 8 0.0000
686 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
687 FLUSHING 4 0.0000
688 BLOOD PRESSURE INCREASED 6 0.0000
689 FALL 13 0.0000
690 DIARRHOEA 25 0.0000
691 RASH GENERALISED 1 0.0000
692 HAEMATOMA 1 0.0000
693 EXPOSURE VIA SKIN CONTACT 1 0.0000
694 FATIGUE 30 0.0000
695 DIPLOPIA 1 0.0000
696 MUCOSAL INFLAMMATION 1 0.0000
697 SEDATION 1 0.0000
698 MUSCULOSKELETAL PAIN 2 0.0000
699 SPEECH DISORDER 2 0.0000
700 APPLICATION SITE ERYTHEMA 1 0.0000
701 MUSCLE SPASMS 7 0.0000
702 ANHEDONIA 1 0.0000
703 GASTRITIS 1 0.0000
704 INJECTION SITE HAEMORRHAGE 3 0.0000
705 PAIN 23 0.0000
706 BREAST CANCER FEMALE 1 0.0000
707 CARDIAC FAILURE CONGESTIVE 3 0.0000
708 PRODUCT USE ISSUE 7 0.0000
709 JAUNDICE 1 0.0000
710 PAIN OF SKIN 1 0.0000
711 DISTURBANCE IN ATTENTION 2 0.0000
712 THROAT TIGHTNESS 1 0.0000
713 ANAEMIA 7 0.0000
714 GAIT DISTURBANCE 7 0.0000
715 TREATMENT NONCOMPLIANCE 2 0.0000
716 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
717 RESPIRATORY DISTRESS 1 0.0000
718 ANAPHYLACTIC REACTION 2 0.0000
719 DIVERTICULITIS 1 0.0000
720 PROCEDURAL PAIN 1 0.0000
721 MENTAL STATUS CHANGES 1 0.0000
722 SEPSIS 4 0.0000
723 WEIGHT INCREASED 8 0.0000
724 HYPONATRAEMIA 2 0.0000
725 ASTHMA 4 0.0000
726 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
727 RED BLOOD CELL COUNT DECREASED 1 0.0000
728 ANGINA PECTORIS 1 0.0000
729 HYPOTENSION 7 0.0000
730 PANCREATIC CARCINOMA 1 0.0000
731 MYOCARDIAL INFARCTION 6 0.0000
732 NEEDLE ISSUE 1 0.0000
733 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
734 DYSPHONIA 2 0.0000
735 SURGERY 2 0.0000
736 PSYCHOTIC DISORDER 1 0.0000
737 INSOMNIA 9 0.0000
738 CATARACT 2 0.0000
739 GASTROINTESTINAL DISORDER 3 0.0000
740 DEVICE ISSUE 3 0.0000
741 IRRITABILITY 2 0.0000
742 CORONARY ARTERY DISEASE 1 0.0000
743 THERAPEUTIC RESPONSE DECREASED 2 0.0000
744 STOMATITIS 2 0.0000
745 ILL-DEFINED DISORDER 2 0.0000
746 CONDITION AGGRAVATED 10 0.0000
747 INJECTION SITE RASH 1 0.0000
748 DRUG ADMINISTRATION ERROR 1 0.0000
749 EMOTIONAL DISORDER 1 0.0000
750 INJECTION SITE ERYTHEMA 4 0.0000
751 CARDIAC DISORDER 3 0.0000
752 NERVOUS SYSTEM DISORDER 1 0.0000
753 MOOD SWINGS 1 0.0000
754 MOVEMENT DISORDER 1 0.0000
755 HYPERHIDROSIS 4 0.0000
756 RHINORRHOEA 2 0.0000
757 ATRIAL FIBRILLATION 3 0.0000
758 PSORIASIS 4 0.0000
759 CHOLELITHIASIS 1 0.0000
760 OSTEONECROSIS 1 0.0000
761 EYE DISORDER 1 0.0000
762 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
763 BACK PAIN 7 0.0000
764 DIZZINESS 15 0.0000
765 SYNCOPE 3 0.0000
766 INJECTION SITE PRURITUS 2 0.0000
767 TYPE 2 DIABETES MELLITUS 1 0.0000
768 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
769 CEREBROVASCULAR ACCIDENT 5 0.0000
770 MYALGIA 5 0.0000
771 HEPATIC ENZYME INCREASED 2 0.0000
772 VISION BLURRED 4 0.0000
773 BURNING SENSATION 2 0.0000
774 HYPERKALAEMIA 1 0.0000
775 DEVICE MALFUNCTION 2 0.0000
776 HYPOXIA 1 0.0000
777 SLEEP DISORDER 2 0.0000
778 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
779 PLATELET COUNT DECREASED 3 0.0000
780 PRODUCT ADHESION ISSUE 1 0.0000
781 CEREBRAL HAEMORRHAGE 1 0.0000
782 MOBILITY DECREASED 2 0.0000
783 VOMITING 13 0.0000
784 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
785 AGITATION 2 0.0000
786 PAIN IN EXTREMITY 8 0.0000
787 DYSARTHRIA 1 0.0000
788 ARTHRALGIA 11 0.0000
789 ACNE 2 0.0000
790 INJECTION SITE SWELLING 2 0.0000
791 CHILLS 3 0.0000
792 ABNORMAL BEHAVIOUR 1 0.0000
793 RASH 11 0.0000
794 DYSKINESIA 1 0.0000
795 OFF LABEL USE 21 0.0000
796 RHABDOMYOLYSIS 1 0.0000
797 CARDIO-RESPIRATORY ARREST 1 0.0000
798 LOSS OF CONSCIOUSNESS 3 0.0000
799 RECTAL HAEMORRHAGE 1 0.0000
800 DEVICE DISLOCATION 1 0.0000
801 INTENTIONAL PRODUCT MISUSE 2 0.0000
802 MUSCULOSKELETAL STIFFNESS 2 0.0000
803 ANGIOEDEMA 1 0.0000
804 DRY SKIN 3 0.0000
805 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
806 ADVERSE DRUG REACTION 2 0.0000
807 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
808 SUICIDAL IDEATION 2 0.0000
809 SKIN DISCOLOURATION 1 0.0000
810 COGNITIVE DISORDER 1 0.0000
811 SWELLING 2 0.0000
812 PULMONARY EMBOLISM 2 0.0000
813 DISEASE RECURRENCE 1 0.0000
814 RENAL CANCER 1 0.0000
815 RASH ERYTHEMATOUS 1 0.0000
816 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
817 LEUKOPENIA 1 0.0000
818 HAEMORRHAGE 2 0.0000
819 ECZEMA 1 0.0000
820 PARAESTHESIA 3 0.0000
821 PANCREATITIS 1 0.0000
822 DRUG INTERACTION 3 0.0000
823 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
824 DRUG DEPENDENCE 3 0.0000
825 DRUG EFFECT DECREASED 1 0.0000
826 OVERDOSE 4 0.0000
827 RASH PRURITIC 1 0.0000
828 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
829 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
830 URTICARIA 3 0.0000
831 NECK PAIN 1 0.0000
832 CONVULSION 1 0.0000
833 LETHARGY 1 0.0000
834 SEIZURE 2 0.0000
835 BLADDER CANCER 1 0.0000
836 DISEASE PROGRESSION 2 0.0000
837 WHEEZING 1 0.0000
838 JOINT SWELLING 2 0.0000
839 VERTIGO 1 0.0000
840 FEELING HOT 1 0.0000
841 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
842 BLOOD GLUCOSE INCREASED 3 0.0000
843 SWELLING FACE 1 0.0000
844 NEOPLASM MALIGNANT 1 0.0000
845 PRODUCT QUALITY ISSUE 2 0.0000
846 ERYTHEMA 3 0.0000
847 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
848 INJECTION SITE REACTION 1 0.0000
849 RESPIRATORY FAILURE 1 0.0000
850 UNDERDOSE 1 0.0000
851 EPISTAXIS 1 0.0000
852 HOT FLUSH 1 0.0000
853 INJECTION SITE PAIN 4 0.0000
854 INJECTION SITE BRUISING 1 0.0000
855 CARDIAC FAILURE 1 0.0000
856 CONFUSIONAL STATE 2 0.0000
857 INFLUENZA LIKE ILLNESS 1 0.0000
858 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
859 PRODUCT STORAGE ERROR 1 0.0000
860 DRUG WITHDRAWAL SYNDROME 1 0.0000
861 ADVERSE EVENT 1 0.0000
862 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
863 HAEMOGLOBIN DECREASED 1 0.0000
864 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
865 MUSCULAR WEAKNESS 1 0.0000
866 EMOTIONAL DISTRESS 1 0.0000
867 DRUG DOSE OMISSION 1 0.0000
868 PYREXIA 2 0.0000
869 NO ADVERSE EVENT 1 0.0000
870 ALOPECIA 1 0.0000